Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Lan V Pham1, Shengjian Huang2, Hui Zhang2

  • 1Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. miwang@mdanderson.org liazhang@mdanderson.org lvpham@mdanderson.org.

Insights

The BCL-2 inhibitor venetoclax shows efficacy in aggressive B-cell lymphomas. Targeting the PI3K/AKT pathway can overcome venetoclax resistance, offering new therapeutic strategies for diffuse large B-cell lymphoma and mantle cell lymphoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • B-cell lymphoma-2 (BCL-2) is an antiapoptotic protein frequently dysregulated in B-cell lymphomas.
  • Venetoclax, a BCL-2 inhibitor, has shown promise in early clinical trials for non-Hodgkin lymphoma.

Purpose of the Study:

  • To investigate the biological effects and mechanism of action of venetoclax in aggressive B-cell lymphomas, specifically mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL).
  • To identify biomarkers for venetoclax activity and explore combination therapies to enhance treatment response.

Main Methods:

  • Utilized MCL and DLBCL cell lines, primary patient samples, and patient-derived xenograft (PDX) models to assess venetoclax efficacy.
  • Employed proteomics analysis and Western blotting to evaluate mechanisms of response and resistance to venetoclax.

Main Results:

  • High BCL-2 expression correlated with sensitivity to venetoclax in cell lines, patient samples, and PDX models.
  • Venetoclax treatment altered key protein expression and phosphorylation involved in DNA damage response, metabolism, cell growth, and apoptosis.
  • Inhibition of PTEN by venetoclax led to increased AKT pathway activation, making cells susceptible to PI3K/AKT inhibition, even in resistant cells.

Conclusions:

  • Venetoclax demonstrates on-target effects in aggressive B-cell lymphomas.
  • PI3K/AKT inhibition presents a viable strategy to overcome both acquired and intrinsic venetoclax resistance.

Related Concept Videos

Aggression01:47

Aggression

Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.4K
Strategies of Self-Presentation I: Strategic Self-Presentation01:12

Strategies of Self-Presentation I: Strategic Self-Presentation

Strategic self-presentation refers to individuals' intentional efforts to influence how others perceive them. This process is employed in various social and professional settings, such as job interviews, dating, politics, and legal contexts, where individuals seek to shape impressions to gain social or material advantages. While people generally present themselves in ways that align with their authentic characteristics, external factors, such as cognitive load, can hinder their ability to...
229
Secondary Motives: Affiliation Motivation and Aggression Motivation01:21

Secondary Motives: Affiliation Motivation and Aggression Motivation

Affiliation motivation is the intrinsic desire to connect with others and belong to a social group, which plays a crucial role in forming and maintaining personal relationships. This type of motivation is essential for psychological well-being, as it provides individuals with a sense of community and support. An example of this is a student who joins a study group in order to feel a sense of connection. People with high affiliation motivation actively seek social approval, take satisfaction in...
725
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
214
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K